Leprosy [Hansen’s disease]
- A30 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
- The 2024 edition of ICD-10-CM A30 became effective on October 1, 2023.
- This is the American ICD-10-CM version of A30 – other international versions of ICD-10 A30 may differ.
Type 1 Excludes
- sequelae of leprosy (B92)
Includes
- infection due to Mycobacterium leprae
The following code(s) above A30 contain annotation back-references
that may be applicable to A30:
- A00-B99 Certain infectious and parasitic diseases
Clinical Information
- A bacterial granulomatous infection caused by mycobacterium leprae. It is a progressive disease affecting the skin, peripheral nerves, and limbs. If untreated, it causes permanent tissue damage leading to autoamputations.
- A chronic granulomatous infection caused by mycobacterium leprae. The granulomatous lesions are manifested in the skin, the mucous membranes, and the peripheral nerves. Two polar or principal types are lepromatous and tuberculoid.
- Chronic granulomatous infection caused by mycobacterium leprae; granulomatous lesions are manifested in the skin, the mucous membranes, and the peripheral nerves; two polar or principal types are lepromatous and tuberculoid.
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
- 2024 (effective 10/1/2023): No change
Code annotations containing back-references to A30: